The Trial Lawyer Magazine Logo
SUBSCRIBE

The Press Release Crime of Biotech CEO; Impact on Scientific Research

Washington Post; September 23, 2013

Is it a crime for a medical researcher to hype his results? To put a heavy spin on the findings when there are millions of dollars, and possibly lives, at stake?

Just ask W. Scott Harkonen.

“I get four hours for errands, once a week. With good behavior, that could go up to six hours,” the 61-year-old physician said recently. “I feel part of an interned population.”

Once the well-paid head of a publicly traded biotech company called InterMune, Harkonen began six months of home confinement July 1. Several times a day he gets a robo-call that checks to make sure he’s inside. His status is an embarrassment, and few people come to visit.

Of course, things could be worse. A federal prosecutor wanted him to get 10 years in prison. Instead, he got a half-year of home detention in his three-story Tudor in San Francisco. But unless his appeals are successful, he won’t ever be able to work as a pharmaceutical researcher and maybe not as a physician, either.

To read the complete article, please visit washingtonpost.com.

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.

chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram